← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2012Last known activity
Jul 31, 2025
Timeline
2010s
- Jun 1, 2012
The Lymphoma Academic Research Organisation— Founded
Drugs by trial phase (53 distinct, 49 trials)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (33 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Disease
- Hodgkin Disease
- Immunoblastic Lymphadenopathy
- Intraocular Lymphoma
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Neoplasms
Recent trials (50)
- NCT06931652Lead sponsorPhase 2Jul 31, 2025
- NCT06558604Lead sponsorPhase 2Dec 31, 2024
- NCT06284122Lead sponsorPhase 3Jun 7, 2024
- NCT06006117Lead sponsorPhase 3Sep 5, 2023
- NCT04802590Lead sponsorPhase 2Sep 28, 2021
- NCT04974216Lead sponsorPhase 2Sep 15, 2021
- NCT04984837Lead sponsorPhase 2Aug 30, 2021
- NCT04842877Lead sponsorPhase 2Jun 11, 2021
- NCT04703686Lead sponsorPhase 2Mar 30, 2021
- NCT04531046Lead sponsorPhase 2Jan 31, 2021
- NCT03892525Lead sponsorPhase 1Jun 15, 2019
- NCT03593018Lead sponsorPhase 3Sep 30, 2018
- NCT03580408Lead sponsorPhase 2Aug 31, 2018
- NCT03496779Lead sponsorPhase 2Apr 10, 2018
- NCT03458260Lead sponsorPhase 2Mar 26, 2018
Details
- Founded
- Pierre-Bénite, FR Jun 1, 2012
- Last known activity
- Jul 31, 2025